Recent Finacing
Recent Raise
Genoa Pharmaceuticals develops inhaled therapies for idiopathic pulmonary fibrosis, advancing Aerodone (nebulized pirfenidone) into clinical development while running clinical operations in Seattle and nonclinical R&D in San Diego.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors